What You Should Know:
- Today, MedCrypt, the proactive cybersecurity solution provider for medical devices and manufacturers raises $25M in Series B funding led by Intuitive Ventures and Johnson & Johnson Innovation.
- The round included participation from institutional investors Section 32, Eniac Ventures, Anzu Partners, and Dolby Family Ventures. This round of funding brings the company's total to date to $34.4M.
Rising Need for Medical Device Cybersecurity
This round stems
Read More
Johnson & Johnson Innovation
Johnson & Johnson Innovation Launches 3 Collaborations to Advance Healthcare in China
What You Should Know:
- Johnson & Johnson Innovation announces three strategic
collaborations with a focus on advancing healthcare solutions in China.
- The three strategic collaborations are focused on leveraging advances in science and technology to address areas of high unmet medical need across several areas, including discovery science, lung cancer, and medical devices
Johnson & Johnson Innovation, a division of Johnson & Johnson (China) Investment Limited, today
Read More
FDA Approves Cue Health’s Point-of-Care COVID-19 Test Using Nasal Swabs
What You Should Know:
- The Food and Drug Administration (FDA) has awarded Cue Health Emergency Use Authorization (EUA) for its rapid, portable, molecular point of care COVID-19 test.
- The company recently raised $100M in Series C funding from Menlo Park-based Decheng Capital, Foresite Capital, Madrone Capital Partners, Johnson & Johnson Innovation – JJDC, Inc., ACME Capital, and other investment firms.
Cue Health Inc.
(“Cue”), a healthcare
technology company,
Read More
Cue Health Lands $100M to Scale Rapid, Portable, Point-of-Care COVID-19 Test
What You Should Know:
- Cue Health raises $100M to commercialize its portable, molecular diagnostic test capable of detecting SARS-CoV-2, the virus that causes COVID-19, in less than 25 minutes using a simple nasal swab.
- The test is part of the Cue Health Monitoring System, which is designed to be a portable device that can perform a molecular test and connect patients to a mobile health platform that features interventional components such as telemedicine
Read More
Cara Care Nabs $7M to Expand Digital Therapuetic App for Digestive Diseases
Berlin, Germany-based digital health company Cara Care, announced today that it has secured $7 million in Series A funding led by Johnson & Johnson Innovation – JJDC, Inc. (JJDC) and Barcelona-based VC firm Asabys Partners with participation from existing investor Atlantic Labs. Cara Care was part of the Microsoft Accelerator and winner of the GlaxoSmithKline Transforming the Future of Self-Care Challenge in the category “Digital Health Technologies.” Cara Care has raised more than $9
Read More
Bioelectronic Medicine Startup Cala Health Nabs $50M for Wearable Neuromodulation Therapies
Cala Health, Inc., a San Francisco, CA-based bioelectronic medicine company developing wearable therapies for chronic disease has raised $50 million in Series C funding. New investors in the Series C funding round include Novartis, Baird Capital, LifeSci Venture Partners, TriVentures, and others. All existing investors participated in the round, including Johnson & Johnson Innovation – JJDC, Inc. (JJDC), Lux Capital, Lightstone Ventures, Action Potential Venture Capital, dRx Capital, and
Read More
WellDoc, LifeScan Integrate to Create Type 2 Diabetes Management Platform
WellDoc has entered a commercial partnership agreement with LifeScan Inc., a Johnson & Johnson Diabetes Care Company (JJDCC), to deliver a best-in-class digital health solution for individuals living with Type 2 diabetes. The combined offering will seek to create a comprehensive, data-driven and payer-reimbursed program for Type 2 diabetes management.WellDoc’s BlueStar® diabetes management platform and mobile app is the first digital therapeutic approved by the U.S. Food and Drug
Read More
J&J Launches New Incubation Model Focused on Human Health in Europe
Johnson & Johnson is launching a new incubation model in Europe designed to identify and nurture early-stage companies actively pursuing research with the potential to transform human health. The initiative, a collaboration with Janssen Pharmaceutica NV, Inc. (Janssen), will be called Johnson & Johnson Innovation, JLINX (JLINX) will offer scientists and entrepreneurs access to venture funding, R&D expertise and state-of-the-art facilities. JLINX will have a particular focus on
Read More
